EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Olive (Olea europaea L.) Seed as New Source of Cholesterol-Lowering Bioactive Peptides: Elucidation of Their Mechanism of Action in HepG2 Cells and Their Trans-Epithelial Transport in Differentiated Caco-2 Cells

Martina Bartolomei iD, Jianqiang Li iD, Anna Laura Capriotti, Melissa Fanzaga iD, Lorenza d'Adduzio iD, Aldo Laganà iD, Andrea Cerrato iD, Nadia Mulinacci iD, Lorenzo Cecchi iD, Carlotta Bollati iD, Carmen Lammi iD

Nutrients · 2024

DOI: 10.3390/nu16030371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Martina Bartolomei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Milan, 20133 Milan, Italy. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Olea. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Recovery and Resilience Plan (NRRP), Italian Ministry of University and Research funded by the European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The production of olive oil has important economic repercussions in Mediterranean countries but also a considerable impact on the environment. This production generates enormous quantities of waste and by-products, which can be exploited as new raw materials to obtain innovative ingredients and therefore make the olive production more sustainable. In a previous study, we decided to foster olive seeds by generating two protein hydrolysates using food-grade enzymes, alcalase (AH) and papain (PH). These hydrolysates have shown, both in vitro and at the cellular level, antioxidant and antidiabetic activities, being able to inhibit the activity of the DPP-IV enzyme and modulate the secretion of GLP-1. Given the multifunctional behavior of peptides, both hydrolysates displayed dual hypocholesterolemic activity, inhibiting the activity of HMGCoAR and impairing the PPI of PCSK9/LDLR, with an IC50 equal to 0.61 mg/mL and 0.31 mg/mL for AH and PH, respectively. Furthermore, both samples restored LDLR protein levels on the membrane of human hepatic HepG2 cells, increasing the uptake of LDL from the extracellular environment. Since intestinal bioavailability is a key component of bioactive peptides, the second objective of this work is to evaluate the capacity of AH and PH peptides to be transported by differentiated human intestinal Caco-2 cells. The peptides transported by intestinal cells have been analyzed using mass spectrometry analysis, identifying a mixture of stable peptides that may represent new ingredients with multifunctional qualities for the development of nutraceuticals and functional foods to delay the onset of metabolic syndrome, promoting the principles of environmental sustainability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9OleaHumansHep G2 CellsCaco-2 CellsPeptidesCholesterolSeeds

Stichwörter der Autor:innen

LDLRPCSK9cholesterol metabolismfood bioactive peptidesmultifunctional peptides

Substanzen

PCSK9 protein, humanProprotein Convertase 9PeptidesCholesterol

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Milan, 20133 Milan, Italy.
  • Department of Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
  • Department of Neuroscience, Psychology, Drug and Child Health, Pharmaceutical and Nutraceutical Section, University of Florence, 50019 Florence, Italy.
  • Department of Agricultural, Food, Environmental and Forestry Sciences and Technologies, University of Florence, Via Donizetti, 50144 Florence, Italy.

ORCID-Profile: Martina Bartolomei, Jianqiang Li, Melissa Fanzaga, Lorenza d'Adduzio, Aldo Laganà, Andrea Cerrato, Nadia Mulinacci, Lorenzo Cecchi, Carlotta Bollati, Carmen Lammi

Förderung

  • National Recovery and Resilience Plan (NRRP)
  • Italian Ministry of University and Research funded by the European Union

Zitieren

APA

Bartolomei, M., Li, J., Capriotti, A. L., Fanzaga, M., d'Adduzio, L., Laganà, A., Cerrato, A., Mulinacci, N., Cecchi, L., Bollati, C., & Lammi, C. (2024). Olive (Olea europaea L.) Seed as New Source of Cholesterol-Lowering Bioactive Peptides: Elucidation of Their Mechanism of Action in HepG2 Cells and Their Trans-Epithelial Transport in Differentiated Caco-2 Cells. Nutrients. https://doi.org/10.3390/nu16030371

Vancouver

Bartolomei M, Li J, Capriotti AL, Fanzaga M, d'Adduzio L, Laganà A, et al. Olive (Olea europaea L.) Seed as New Source of Cholesterol-Lowering Bioactive Peptides: Elucidation of Their Mechanism of Action in HepG2 Cells and Their Trans-Epithelial Transport in Differentiated Caco-2 Cells. Nutrients. 2024. doi:10.3390/nu16030371

BibTeX
@article{Bartolomei2024,
  author = {Bartolomei, Martina and Li, Jianqiang and Capriotti, Anna Laura and Fanzaga, Melissa and d'Adduzio, Lorenza and Laganà, Aldo and Cerrato, Andrea and Mulinacci, Nadia and Cecchi, Lorenzo and Bollati, Carlotta and Lammi, Carmen},
  title = {Olive (Olea europaea L.) Seed as New Source of Cholesterol-Lowering Bioactive Peptides: Elucidation of Their Mechanism of Action in HepG2 Cells and Their Trans-Epithelial Transport in Differentiated Caco-2 Cells},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16030371}
}
Kostenlos starten →